{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-070114","form_type":"8-K","ticker":"EWTX","cik":"0001710072","company_name":"Edgewise Therapeutics, Inc.","filed_at":"2024-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.690430+00:00","generated_at":"2026-06-01T05:05:29.332510+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Edgewise shareholders elect directors, ratify KPMG, approve officer exculpation charter amendment","bullets":["Elected Class III directors Thompson, Koch, and Fox with 65M–75M shares For vs 6.9M–17.3M Against; broker non-votes 8.2M.","Ratified KPMG LLP as independent auditor for FY 2024: 90.5M For, 4K Against, 35K Abstain.","Approved certificate amendment to limit officer liability per Delaware law: 81.4M For, 938K Against, 1.4K Abstain; broker non-votes 8.2M.","Amendment to Article IX of the certificate of incorporation was filed on June 10, 2024, effective upon filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-070114","json":"https://secwatch.observer/filing/0001104659-24-070114.json","markdown":"https://secwatch.observer/filing/0001104659-24-070114.md","text":"https://secwatch.observer/filing/0001104659-24-070114.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1710072/000110465924070114/0001104659-24-070114-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1710072/000110465924070114/tm2416817d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:05:29.332510+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}